Company intelligence / Profile preview

Bio-Cytomed

New Taipei City, Taiwan

Ownership: Private
Development stage: Other

Overview

Bio-Cytomed is a biotechnology company based in Taiwan that specializes in the development and commercialization of regenerative medicine products. The company focuses on utilizing its proprietary extracellular matrix (ECM) technology to create scaffolds and bioactive materials for tissue engineering and wound management. Their product portfolio includes solutions for chronic wound healing, orthopedic applications such as cartilage repair, and dental regeneration. Bio-Cytomed aims to provide advanced clinical solutions that accelerate the body's natural healing processes through biocompatible and bioactive medical devices.

Therapeutic areas: OtherRheumatologyDermatology
Modalities: Cell therapyBiologicDevice
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Bio-Cytomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Cytomed.

Explore the full profile